Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: PS1 Mutations
PS1P117L (line 13)

Posted 1 April 2005

General Information

Transgene: Tg mice were produced by pronuclear injection of fertilized eggs of C57Bl/6J × DBA/2J (B6D2) F1 hybrids. P117L FAD (Polish) mutant cDNAs were cloned into a neuron-specific enolase (NSE) expression vector.

Mutation: P117L

Promoter: Neuron-specific enolase (NSE) promoter

Mouse Strain: Mixed C57Bl/6 and DBA/2J background. All studies were performed using the hemizygous offspring of transgenic animals mated to B6D2 F1 hybrids with nontransgenic littermates utilized as controls.

Phenotype

Neuropathological Analysis:

Line 13 expresses the hPS1 2-3X the level of the endogenous mPS1. PS1P117L FAD mutant impairs new neuron production in adult hippocampus by decreasing neural progenitor survival. BrdU labeling and IHC showed that the human transgenic proteins are not expressed in neural progenitor cells in the hippocampus as would be expected of an NSE-driven transgene.P117L tg animals do not exhibit plaques or diffuse amyloid deposits at 2-3 months. However, they do overproduce the long 1-42 form of Aß.

Availability

Gregory A. Elder
Department of Psychiatry
Mount Sinai School of Medicine
New York, NY 10029
Email: gregory.elder@mssm.edu

Patents: None

Primary Reference

Wen, P.H., Shao, X., Shao, Z., Hof, P.R., Wisniewski, T., Kelley, K., Friedrich Jr., V.L., Ho, L., Pasinetti, G.M., Shioi, J., Robakis, N.K. and Elder, G.A. Overexpression of wild type but not an FAD mutant presenilin-1 promotes neurogenesis in the hippocampus of adult mice. Neurobiol. Dis. 10:18-19, 2002. ">Abstract

Associated References

Wen PH, Hof PR, Chen X, Gluck K, Austin G, Younkin SG, Younkin LH, DeGasperi R, Gama Sosa MA, Robakis NK, Haroutunian V, Elder GA. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice. Exp Neurol. 188(2):224-37, 2004. Abstract

Wen PH, Friedrich Jr VL, Shioi J, Robakis, NK, Elder, GA. Presenilin-1 is expressed in neural progenitor cells in the hippocampus of adult mice. Neurosci. Lett. 318, pp. 53-56, 2002. Abstract

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad